Pengaruh Inovasi Produk pada Kinerja Keuangan dengan Adopsi Teknologi di Perusahaan XYZ di Indonesia
Sanskara Akuntansi dan Keuangan · 2024
DOI: 10.58812/sak.v2i02.327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sanskara Akuntansi dan Keuangan, 2024. Verfasst von Mohammad Gifari Sono und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
The paper focuses on the impact of product innovation on financial performance. Adoption of technology plays a crucial role in driving product innovation. Measurement of product innovation is done using Likert scale with four indikators. Measurement of technology adoption is done using Likert scale with five indikators. Financial performance is measured using liquidity, solvency, profitability, and activity ratios. The study examines the impact of product innovation on financial performance. Adoption of technology and innovation in products can improve financial performance. The findings provide a basis for companies to focus on innovation and technology adoption. Practical implications include expanding innovation initiatives and investing in human resources. The study has limitations in terms of specific company context and aspects studied.
Zitieren
APA
Sono, M. G., Sudiana, U., Said, S., Utami, E. Y., & Hartati, H. (2024). Pengaruh Inovasi Produk pada Kinerja Keuangan dengan Adopsi Teknologi di Perusahaan XYZ di Indonesia. Sanskara Akuntansi dan Keuangan. https://doi.org/10.58812/sak.v2i02.327
Vancouver
Sono MG, Sudiana U, Said S, Utami EY, Hartati H. Pengaruh Inovasi Produk pada Kinerja Keuangan dengan Adopsi Teknologi di Perusahaan XYZ di Indonesia. Sanskara Akuntansi dan Keuangan. 2024. doi:10.58812/sak.v2i02.327
BibTeX
@article{Sono2024,
author = {Sono, Mohammad Gifari and Sudiana, Urip and Said, Saida and Utami, Eva Yuniarti and Hartati, Hartati},
title = {Pengaruh Inovasi Produk pada Kinerja Keuangan dengan Adopsi Teknologi di Perusahaan XYZ di Indonesia},
journal = {Sanskara Akuntansi dan Keuangan},
year = {2024},
doi = {10.58812/sak.v2i02.327}
}
EUVIMED